Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Colleen Marie Feltmate, M.D.

Concepts (277)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms16202313662.110 Why?
Cystadenocarcinoma, Serous520224781.260 Why?
Vulvar Neoplasms420182631.230 Why?
Ovarian Neoplasms23202248781.210 Why?
Hysterectomy1020238571.180 Why?
Hydatidiform Mole1020082550.780 Why?
Chorionic Gonadotropin1020074570.760 Why?
Leukocytosis220132510.750 Why?
Placenta Accreta120232370.660 Why?
Carcinoma4202223300.610 Why?
Paget Disease, Extramammary12018510.590 Why?
Gynecology120235260.570 Why?
Sentinel Lymph Node Biopsy320207320.560 Why?
Genital Neoplasms, Female320235320.550 Why?
Uterine Cervical Neoplasms6202220200.550 Why?
Obstetrics120236660.530 Why?
Uterine Neoplasms9201014200.500 Why?
Neoplasm Recurrence, Local13202092800.500 Why?
Carcinosarcoma120151060.470 Why?
Adenocarcinoma, Clear Cell120152170.440 Why?
Laparoscopy6202220360.440 Why?
MutS Homolog 2 Protein120121970.400 Why?
Papillomaviridae1201811190.400 Why?
Trophoblastic Tumor, Placental Site22002200.390 Why?
Papillomavirus Infections3202116130.380 Why?
Fallopian Tube Neoplasms520183280.380 Why?
Carcinoma in Situ320187910.380 Why?
Genes, BRCA2220136010.370 Why?
Adenocarcinoma5201763450.370 Why?
Genes, BRCA1220137640.350 Why?
Cell Transformation, Neoplastic2201828270.330 Why?
Carcinoma, Endometrioid320202760.310 Why?
Neoplasms, Multiple Primary120125920.310 Why?
Neoplasm Staging162022111200.310 Why?
Endometriosis220148700.300 Why?
Carcinoma, Squamous Cell3201840240.300 Why?
Neoplasms, Cystic, Mucinous, and Serous220201940.280 Why?
Loss of Heterozygosity220056620.270 Why?
Adenocarcinoma, Mucinous320145170.260 Why?
Ovariectomy420136140.250 Why?
Germ-Line Mutation1201318580.250 Why?
Microdissection120051510.240 Why?
Female7020233927050.240 Why?
Heterozygote2201227870.220 Why?
Appendiceal Neoplasms120051550.220 Why?
Lymphatic Metastasis4202029150.220 Why?
Internship and Residency1202358820.210 Why?
BRCA2 Protein220238050.210 Why?
Chemotherapy, Adjuvant6202135140.200 Why?
Robotics320158190.200 Why?
Immunohistochemistry52020110760.200 Why?
Brachytherapy3202012230.200 Why?
Retrospective Studies242022806470.200 Why?
Patient Discharge1201534430.200 Why?
BRCA1 Protein2202311580.180 Why?
Lasers120059520.180 Why?
Gynecologic Surgical Procedures320232840.180 Why?
Preoperative Period220135510.170 Why?
Aged2920211693100.170 Why?
Treatment Refusal120034290.170 Why?
Middle Aged3420212209210.170 Why?
Humans7120237615960.160 Why?
Pregnancy182023298900.160 Why?
Lymph Node Excision3202012710.160 Why?
Uterus120226490.160 Why?
Prognosis102020296290.160 Why?
Neoplasms, Glandular and Epithelial220134870.150 Why?
Alphapapillomavirus120212180.150 Why?
Aged, 80 and over152021589840.150 Why?
Education, Medical, Continuing120238230.150 Why?
Fallopian Tubes120181780.150 Why?
Cyclin-Dependent Kinase Inhibitor p16120216980.150 Why?
Genome1200517400.140 Why?
Adult3320212212100.140 Why?
Cervix Uteri120215700.140 Why?
Alleles2200568640.140 Why?
Neoplasm Invasiveness4202035970.130 Why?
Antimetabolites, Antineoplastic220106460.130 Why?
Ovarian Cysts120161080.120 Why?
Genome, Human2200544250.120 Why?
Early Detection of Cancer2202132010.120 Why?
Neoplastic Syndromes, Hereditary120172450.120 Why?
Placenta1202317090.110 Why?
Radiotherapy, Adjuvant2202017840.110 Why?
Neoadjuvant Therapy5202128280.110 Why?
Ovarian Diseases120141370.110 Why?
Antineoplastic Combined Chemotherapy Protocols42018117420.110 Why?
Precancerous Conditions220189800.110 Why?
Disease-Free Survival6202268150.110 Why?
CA-125 Antigen220132810.110 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120173800.100 Why?
Methotrexate2201017190.100 Why?
Risk Factors112023742130.100 Why?
Organoids120187460.100 Why?
New England2200610540.100 Why?
Perioperative Care2202010360.090 Why?
Ovary120169590.090 Why?
Cadherins120169030.090 Why?
Genotype12005129900.090 Why?
High-Throughput Nucleotide Sequencing2202036390.090 Why?
Cohort Studies82023414950.090 Why?
Cell Lineage1201825570.080 Why?
Postoperative Complications42023156330.080 Why?
DNA Repair1201820460.080 Why?
Clinical Protocols1201514400.080 Why?
Gene Expression Regulation, Neoplastic2202085540.080 Why?
Granulosa Cell Tumor12009770.080 Why?
Peritoneal Neoplasms220137110.080 Why?
Cell Proliferation32020104510.080 Why?
Death120136760.080 Why?
Venous Thromboembolism1202118660.070 Why?
Human papillomavirus 16120102670.070 Why?
Pregnancy Complications, Neoplastic120102580.070 Why?
Survival Rate32020127230.070 Why?
Surgery, Computer-Assisted1201510070.070 Why?
Gravidity12006500.070 Why?
Insurance Coverage1201819400.070 Why?
Epithelial Cells1201836770.070 Why?
Incidence42021213550.070 Why?
Insurance, Health1201824990.060 Why?
Lymph Nodes1201734650.060 Why?
Dilatation and Curettage12004520.060 Why?
Pelvic Neoplasms120072470.060 Why?
Remission Induction2201023970.060 Why?
Blood Vessels1201011130.060 Why?
Exercise1202158900.060 Why?
Tumor Suppressor Protein p534202029170.060 Why?
Feasibility Studies3202152470.060 Why?
Cell Movement1201652050.060 Why?
Anesthesia1201515950.060 Why?
Ki-67 Antigen120066290.060 Why?
Maternal Age120068090.050 Why?
Angiogenesis Inhibitors1201320480.050 Why?
Prospective Studies62021544230.050 Why?
Radiotherapy Dosage3201528980.050 Why?
Telemedicine1202130520.050 Why?
Tumor Cells, Cultured3202061310.050 Why?
Evidence-Based Medicine1201536880.050 Why?
Genetic Techniques120054280.050 Why?
Kaplan-Meier Estimate3201964840.050 Why?
Registries5201882250.050 Why?
Medical Records2200614080.050 Why?
Artifacts1201019110.050 Why?
Genetic Predisposition to Disease32018179040.050 Why?
Ultrasonography1201459710.050 Why?
Sialoglycoproteins120023150.050 Why?
Pregnancy Complications1201429470.040 Why?
Intraoperative Complications1200711660.040 Why?
Predictive Value of Tests52020152660.040 Why?
Recurrence1201384660.040 Why?
Colposcopy120211500.040 Why?
Follow-Up Studies42018391060.040 Why?
Chorionic Gonadotropin, beta Subunit, Human22010810.040 Why?
Adnexa Uteri12019400.040 Why?
Germ Cells120236340.040 Why?
Neoplasms, Second Primary1200710520.040 Why?
Patient Readmission1201332710.040 Why?
Omentum120191680.040 Why?
Online Systems120191820.040 Why?
Estrogen Replacement Therapy2199512080.040 Why?
Diagnosis, Differential52018129730.040 Why?
Endometrium120204030.040 Why?
Genital Diseases, Female119991920.040 Why?
Estradiol2199519370.040 Why?
Pregnancy Outcome1200829220.040 Why?
Treatment Outcome42019646850.040 Why?
Diagnostic Tests, Routine120037870.040 Why?
Enzyme-Linked Immunosorbent Assay2202138100.040 Why?
Blood Loss, Surgical120216380.040 Why?
Colorectal Neoplasms1201769380.030 Why?
Sensitivity and Specificity42021146650.030 Why?
Organ Culture Techniques120187950.030 Why?
Mutation42018300530.030 Why?
Gene Expression Profiling2201694200.030 Why?
Brain Neoplasms1201790320.030 Why?
Carboplatin120187940.030 Why?
Drug Resistance, Neoplasm1201053050.030 Why?
Referral and Consultation2202136000.030 Why?
Microtubule-Associated Proteins1202010760.030 Why?
Length of Stay2202364260.030 Why?
Lymphocytes, Tumor-Infiltrating1202010920.030 Why?
Massachusetts3201888330.030 Why?
HeLa Cells1202130940.030 Why?
Deoxycytidine120188770.030 Why?
Estrone119952340.030 Why?
Triage120219860.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201645760.030 Why?
Polysaccharides1202010140.030 Why?
Organs at Risk120153590.030 Why?
Observer Variation1201926060.030 Why?
Prolactin119956250.030 Why?
Pyrazines1201812020.030 Why?
Apoptosis2202094900.030 Why?
Patient Positioning120153260.030 Why?
Xenograft Model Antitumor Assays1202036050.020 Why?
Appendicitis119996750.020 Why?
Fluorodeoxyglucose F181202020090.020 Why?
Obesity12014129470.020 Why?
Adolescent52020883260.020 Why?
Fluorescent Antibody Technique1201624670.020 Why?
Killer Cells, Natural1202022010.020 Why?
DNA Replication1201814180.020 Why?
Hyperglycemia1202013760.020 Why?
Motivation1202120060.020 Why?
Radiopharmaceuticals1202026500.020 Why?
Cancer Care Facilities120134220.020 Why?
Organoplatinum Compounds120124070.020 Why?
Dactinomycin120103040.020 Why?
Gravitation12009820.020 Why?
Risk2201496100.020 Why?
Etoposide120106340.020 Why?
Microscopy, Fluorescence1201626450.020 Why?
Taxoids120126680.020 Why?
Ethanol1199513240.020 Why?
Biopsy1202067660.020 Why?
Combined Modality Therapy2201485270.020 Why?
Cell Culture Techniques1201616680.020 Why?
Pyrazoles1201820090.020 Why?
Magnetic Resonance Imaging12015364260.020 Why?
Pilot Projects1202186330.020 Why?
Gene Regulatory Networks1201617450.020 Why?
Radiotherapy, Intensity-Modulated120138010.020 Why?
Contraceptives, Oral120095540.020 Why?
CD8-Positive T-Lymphocytes1202045800.020 Why?
Neoplasm, Residual1201210080.020 Why?
Risk Assessment32020239960.020 Why?
Menopause1199516460.020 Why?
Radiotherapy Planning, Computer-Assisted1201516600.020 Why?
Tomography, X-Ray Computed22020205680.020 Why?
Parity120099270.020 Why?
Curettage12005740.020 Why?
Postmenopause1199525130.020 Why?
Consensus1201531240.020 Why?
RNA, Messenger22016127940.020 Why?
Blood Glucose1202063910.020 Why?
Insulin1202065970.020 Why?
Alcohol Drinking2199540280.020 Why?
Organ Size1201022540.020 Why?
Genes, p53120077120.010 Why?
Family Health1200912570.010 Why?
Cyclophosphamide1201022200.010 Why?
Radiography1201569650.010 Why?
Body Mass Index22014129530.010 Why?
Decision Trees120065040.010 Why?
Randomized Controlled Trials as Topic12021102120.010 Why?
DNA Methylation1201743990.010 Why?
Neoplasm Metastasis1201349150.010 Why?
Administration, Cutaneous219957130.010 Why?
Apoptosis Regulatory Proteins1200711360.010 Why?
Survival Analysis12014100900.010 Why?
Age Distribution1200728790.010 Why?
Risk Reduction Behavior1200711120.010 Why?
Reproducibility of Results22014201000.010 Why?
Phenotype12018165920.010 Why?
Practice Guidelines as Topic1201873910.010 Why?
Osteopontin120023010.010 Why?
Cluster Analysis1200627070.010 Why?
Ultrasonography, Prenatal1200717550.010 Why?
Cross-Over Studies2199520790.010 Why?
Oligonucleotide Array Sequence Analysis1200637790.010 Why?
Clinical Trials as Topic1201380020.010 Why?
Positron-Emission Tomography1201364840.010 Why?
Cell Differentiation12014115300.010 Why?
Patient Compliance1200426900.010 Why?
Mice12020815390.010 Why?
Young Adult12020592600.010 Why?
Age Factors12009183990.010 Why?
Case-Control Studies12009221760.010 Why?
Random Allocation1199523950.010 Why?
Gene Expression1200275810.010 Why?
Animals120201684750.000 Why?
Acute Disease1199972370.000 Why?
Male120053608460.000 Why?
Analysis of Variance1199562280.000 Why?
Double-Blind Method11995123410.000 Why?
United States12004723400.000 Why?
Child11999801580.000 Why?
Feltmate's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (277)
Explore
_
Co-Authors (76)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.